Tempus AI Investors: A Call to Action for Class Action Lawsuit
Investors holding common stock in Tempus AI, Inc. (NASDAQ: TEM) between August 6, 2024, and May 27, 2025, are being urged to consider taking legal action as part of a class action lawsuit. This solicitation comes from Robbins Geller Rudman & Dowd LLP, a law firm known for representing investors in securities fraud cases. The opportunity arises due to significant losses reported by investors during this period, suggesting potential wrongdoing by the company and its executives.
Allegations Against Tempus AI
The class action lawsuit, known as
Shouse v. Tempus AI, Inc., is set against a backdrop of alleged violations of the Securities Exchange Act of 1934. The suit claims that Tempus AI, along with certain senior executives, made false or misleading statements that misled shareholders about the company's operational integrity and financial health. Specifically, the complaint details several troubling practices that may have inflated the company's stock value artificially.
Allegations include:
- - Inflated Contracts: It is claimed that Tempus AI inflated the value of numerous contract agreements, some of which were with related parties, and included non-binding opt-ins.
- - Joint Venture Issues: The credibility of Tempus AI’s joint venture with SoftBank Group Corporation is under scrutiny, with claims that it appeared to involve deceptive practices known as “round-tripping.”
- - Revenue Concerns: The acquisition of Ambry Genetics Corporation raised concerns about aggressive and possibly unethical billing practices, possibly endangering long-term revenue sustainability.
- - Reduced Financial Commitments: AstraZeneca PLC reportedly lowered its financial commitments to Tempus AI through a joint agreement, prompting questions about the legitimacy of these dealings.
- - Operational Weakness: Overall, these issues have revealed a concerning weakness in Tempus AI's operations and future revenue prospects, casting a shadow over its financial integrity.
Stock Price Impact
The situation escalated when Spruce Point Capital Management issued a report highlighting these concerns, resulting in a significant drop in Tempus AI's stock price—over 19%—shortly after its publication. This decline has undoubtedly exacerbated the financial losses faced by many investors, making the potential class action a crucial point of recovery for victims of this alleged corporate misconduct.
Becoming a Lead Plaintiff
The
Private Securities Litigation Reform Act of 1995 allows any investor who purchased Tempus AI common stock during the specified class period to seek appointment as lead plaintiff in the lawsuit. This position is typically filled by the individual with the greatest financial interest in the outcome of the case who is also representative of the group's interests.
If appointed, the lead plaintiff will play a key role in guiding the lawsuit and may select the law firm of their choosing to pursue the case. Importantly, an investor's ability to benefit from any potential settlements or recoveries does not hinge on their role as lead plaintiff.
About Robbins Geller
Founded as a leading law firm in investor rights litigation, Robbins Geller Rudman & Dowd LLP has an esteemed track record. In 2024 alone, the firm secured over $2.5 billion for investors involved in class action suits—outperforming its rivals in the securities litigation arena. Notably, Robbins Geller attorneys have participated in recovering some of the largest disbursements from securities fraud cases in history.
For those interested in pursuing the opportunity to feature prominently in this class action lawsuit, contacting the team members at Robbins Geller, specifically attorneys J.C. Sanchez or Jennifer N. Caringal, is advisable. They can provide further information and clarity on the steps to take for class participation. Investors are encouraged to act before the deadline of August 12, 2025, to ensure their claims are recognized.
The path to justice through the class action process can be a vital avenue for recovering losses and holding corporate wrongdoing accountable.
For more detailed instructions, visit
Robbins Geller's website or reach the firm's attorneys at 800-449-4900.